While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in ...

The United States is home to one of the leading healthcare systems globally, primarily due to its remarkable ability to drive ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Jonathan Zhu, Co-head of Asia Private Equity at Bain Capital says China's tech sector playing field is still large despite ...

Naloxone is a life-saving medication which helps reverse the effects of an opioid overdose. Improving naloxone access is a central pillar of the federal response to the worsening opioid crisis in the ...

Industry experts from across 100 countries will descend on Riyadh this December for launch event of most comprehensive pharma ...

With more than $80 million in hand, the University of Texas MD Anderson Cancer Center has launched its own cell therapy ...

Dr. Najiba Al Shezawy, Co-Chairman of AfriSummit, expressed her gratitude for the participation of African National ...

On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...

Revenue Exceed RMB30.9 Billion with R&D Expenditure RMB3.9 Billion Continuing to Consolidate its Dominant Position In The fields of Breast Cancer and Lung Cancer ...